Class II · Moderate riskTerminated Initiated Jan 9, 2019 (8 years ago)
Cephalexin for Oral Suspension USP 250mg/5 mL, Rx Only Manufactured for: Lupin…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations; presence of extraneous material in the was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven bag) of sucrose (an excipient) used in the finished product.
What was recalled
Cephalexin for Oral Suspension USP 250mg/5 mL, Rx Only Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited Mandideep 462 046 India --- NDC 68180-441-01
Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-441-01
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0423-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of…